Author

Yuki Hamada

Kyoto UniversityORCID 0000-0002-3341-6083Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Daisuke Yarimizu· 1 shared Emi HasegawaiD· 1 shared Hikari Uehara· 1 shared Masao DoiiD· 1 shared Takehide Sakamoto· 1 shared Tom MacphersoniD· 1 shared Xinyan Shao· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Daisuke Yarimizu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NAD boosting by CD38 inhibition drives reversal of a pathological vicious cycle of intracrine activity and inflammation in eyelid meibomian gland involution

Yuki Hamada, Takehide Sakamoto, Daisuke Yarimizu, Hikari Uehara, Xinyan Shao, Tom Macpherson, Emi Hasegawa, Masao Doi

This study shows that inhibiting CD38 boosts NAD levels, reversing a harmful cycle of inflammation and reduced intracrine activity in aged meibomian glands.

bioRxiv · Nov 1, 2026 · PreprintPathology